About this trial
Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with benign tracheal stenosis
Disqualifiers
Malignancy. active infection
Trial population
patients with benign tracheal stenosis, including idiopathic, iatrogenic, autoimmune.
Trial design
Case-only
Prospective
Treatments tested in this trial
Biopsy or surgery
Procedure/SurgeryThe tissue will be obtained from biopsy or surgical resection. All the "intervention" will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue
Treatment groups
Trial outcomes
Primary outcomes
RNA profile
The diseased mucosa will show a increased fibrosis and inflammation profile compared with that from normal mucosa
Sponsors and contacts
Click on the lead sponsor to view all of their trials.